Trials / Conditions / Locally Advanced Unresectable Gastric Adenocarcinoma

Locally Advanced Unresectable Gastric Adenocarcinoma

5 registered clinical trials studyying Locally Advanced Unresectable Gastric Adenocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Can NCT05974059	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Recruiting	Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv NCT04660760	Academic and Community Cancer Research United	Phase 2
Withdrawn	MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma NCT03739801	University of Southern California	Phase 1 / Phase 2
Unknown	Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metast NCT04263870	Sichuan University	Phase 2